Sat, Sep 20, 2014, 8:25 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • deadingo deadingo Aug 17, 2000 5:00 AM Flag

    LET'S FACE IT......

    nothing the bashers, spammers, shorts, losers,
    competitors, etc. may say will make any difference to those
    willing to take the RISK to invest in this company long
    term... and it is a RISK as with ANY other Biotech. Aside
    from those who will hear no wrong about Onyx 015,
    there are various problems which need to be overcome
    before the product is acceptable. However, having said
    that, ONYX ie. Frank McCormick et al, were the FIRST to
    initiate adenovirus research for cancer treatment. The
    science and the brains behind the business count for
    something - regardless of the hype.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • How many times do I have to tell you? There is no
      reason for me to run and put out every little fire you
      start. I did my DD and if it wasn't enough I will take
      my lumps at a later date like you are taking them
      now. I am not concerned.

      I believe by 'global'
      you mean systemic. Thoughout the body. To get
      satellite tumors.

      Now you'll probably launch into a
      discussion of how Onyx's method only works locally. Don't
      bother. I have other things to do then sit around waiting
      for your next little hand grenade that is having
      absolutely no effect. Onyx's method is elegant, it is
      brilliant and it works. If it doesn't cure all cancers in
      one treatment, that's too bad. In that case the
      company will end up making even more money,
      however.

      As I said. We can talk again in a year. Hope you're
      still here.

    • If you would like to act like you know something explain the use of local versus global treatment for recurrent head and neck cancer in this case?

    • microcap

      10-K PATENT
      WARNING

      cont'd

      this pertain to the viruses further back
      in ONXX's pipeline

      Specifically, we are aware
      of patent applications filed in the United States
      and abroad that, if they were to issue, would cover
      ONYX-015 and other selectively-replicating viruses, and we
      are aware of patent applications that claim enzymes
      for converting prodrugs to their active forms for
      treating disease, including cancers, and methods of
      delivering the enzymes using a virus. If any of these
      patents are issued and we are unable to successfully
      challenge any claims asserting that our product candidates
      or products infringe the patent, or design around
      the patent or negotiate a reasonable license under
      the patent, our business, financial condition and
      results of operations would be seriously harmed.


      I posted a link for a patent covering the use of
      cytokine and prodrug activator in adenovirus - there are
      tons of patents covering them - none licensed to onyx
      by name

    • Joe went over this patent issue, and P just kept
      wriggling away, slippery as an eel. I asked him why Pfizer
      doesn't show the concern over the issue that he does,
      after as 10 huor pause, well you saw his lame
      remark.
      AZ

    • clowncompanyentertainsme clowncompanyentertainsme Aug 17, 2000 1:36 PM Flag

      had to be a short.

    • I am busy today - I can respond to your layman
      off-based ideas later or tomorrow.

      If you would like
      I will go through the arduous process of taking
      apart the 10-k and publishing manuscripts which cast
      serious doubt on ONXX's claim of any level of superiority
      for the treatment of recurrent cancer. Maybe about 50
      more posts comparing ONXX to competitors and novel
      chemo/radiation therapy protocols

    • Nonesense, pinvestment. I bought this company
      when the stock was going nowhere, at 11 5/8, and I
      bought it on fundamental grounds, not as a momentum
      trade. It had no momentum then.

      As I told you
      before, I have no need to track down every one of your
      little grenades and put the pin back in. I already did
      my DD and reached a conclusion that I am extremely
      comfortable with. You reached another one, or so you claim.
      Fine. Let's chat again in about a year.

    • microcap

      this is not innuendo

      this
      is a link from the 10-k which contains a patent
      warning

      Specifically, we are aware of patent applications filed in the
      United States and abroad that, if they were to issue,
      would cover ONYX-015 and other selectively-replicating
      viruses, and we are aware of patent applications that
      claim enzymes for converting prodrugs to their active
      forms for treating disease, including cancers, and
      methods of delivering the enzymes using a virus. If any
      of these patents are issued and we are unable to
      successfully challenge any claims asserting that our product
      candidates or products infringe the patent, or design around
      the patent or negotiate a reasonable license under
      the patent, our business, financial condition and
      results of operations would be seriously harmed.


      This is the patent recently issued to a direct
      competitor of ONXX

      EP1008653A2: Recombinant
      adenoviral vector with limited capability to self-replicate


      Here is the
      link

      http://www.patents.ibm.com/details?pn=EP01008653A2

      Innuendo or hearsay is that fact that someone at the ASGT
      meeting in May said that a company with a recent patent
      covering replication competent adenoviruses - was going to
      sue to put a business called calydon out of business
      and that ONXX was potentially in their sights too.

    • company. He only repeats negative claims and
      generates posits that are intended to run down ONXX. I
      would say that he is failing, judging from the movement
      of the stock. But then, what do all these people
      know. P knows better.
      In my opinion.
      AZErnie

    • You do not understand surgical and medical
      treatment of tumors - not by a long shot - the only thing
      that makes you think you know something is a stock
      price that is going up. I wrote a message to AZernie
      late last night it outlines a couple of points on why
      ONYX015 will never be a front line therapy for anything,
      please take a look I am willing to clarify points if
      needed.

    • View More Messages
 
ONXX
124.700.00(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TC PipeLines, LP
NYSEFri, Sep 19, 2014 4:00 PM EDT